Sangamo Therapeutics
SGMO
SGMO
170 hedge funds and large institutions have $955M invested in Sangamo Therapeutics in 2017 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 54 increasing their positions, 49 reducing their positions, and 20 closing their positions.
Holders
170
Holders Change
+22
Holders Change %
+14.86%
% of All Funds
3.86%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
43
Increased
54
Reduced
49
Closed
20
Calls
$34.4M
Puts
$24.7M
Net Calls
+$9.74M
Net Calls Change
+$4.42M
Top Buyers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$87.8M |
2 |
2
State Street
Boston,
Massachusetts
|
$65.3M |
3 |
AC
3
Alexandria Capital
Arlington,
Virginia
|
$15.2M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$73.5M |
5 |
PP
5
PDT Partners
New York
|
$7.74M |